Search

everythinglearnresearchcommunity

for

Search:↓

A mutation in the SREBF1 gene causes both hereditary mucoepithelial dysplasia and IFAP syndrome, which are related conditions.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

The PER3 rs772027021 SNP may cause mild skin pigmentation changes in a new subtype of dyschromatosis universalis hereditaria.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

A new DSG4 gene mutation causes hair defects in a young girl.

Blocking a protein called prostaglandin D2 might help treat hair loss.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

New mutations in the DSG4 gene cause a rare hair condition.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Certain genetic variations are linked to hair loss in Mexican men.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

GFRα2 is essential for controlling neuron size but not for target innervation in certain sensory neurons.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Hair loss gene linked to prostate issues.